What are the steps for diagnosing and treating HIV (Human Immunodeficiency Virus) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIV Diagnosis and Treatment Protocol

The diagnosis of HIV infection requires a systematic approach using serologic tests for antibody detection, followed by confirmatory testing, and then appropriate treatment initiation based on clinical staging. 1

Diagnostic Process

Initial HIV Testing

  • Screening test: Begin with a sensitive screening test such as enzyme-linked immunosorbent assay (ELISA) or rapid assay 1
    • Fourth-generation assays that detect both HIV antibodies and p24 antigen are recommended as initial screening tests 1
    • These tests can detect infection earlier (4-7 days after infection) compared to antibody-only tests 1

Confirmation of Positive Results

  • All reactive screening tests must be confirmed by:
    • Western blot or indirect immunofluorescence assay (IFA) 1
    • For fourth-generation assays, follow with an antibody immunoassay that distinguishes HIV-1 from HIV-2 antibodies 1

Special Testing Considerations

  • For suspected acute infection (within 4 weeks of exposure):

    • Consider HIV RNA testing (viral load) as antibodies may not yet be detectable 1
    • HIV RNA becomes positive 3-5 days before p24 antigen 1
  • For infants born to HIV-positive mothers:

    • Antibody tests are unreliable due to maternal antibody persistence
    • Use HIV DNA PCR or RNA PCR tests for diagnosis 1
    • Definitive determination for infants under 15 months requires laboratory evidence of HIV in blood or tissues 1
  • For suspected HIV-2 infection:

    • Consider testing if patient is from West Africa or has epidemiological links to areas with HIV-2 prevalence 1
    • Use the Multispot rapid test which is FDA-approved for differentiating HIV-1 from HIV-2 1

Testing Frequency

  • Persons with known high-risk behaviors should be tested at least annually 1
  • For HIV PrEP users, testing should be repeated at least every 3 months 2
  • After high-risk exposure, if initial test is negative, repeat testing at 6,12, and 24 weeks 1

Post-Diagnosis Assessment

Medical History

  • Document date of diagnosis and approximate date of infection if possible 1
  • Obtain thorough medication history, especially for patients with prior antiretroviral therapy 1
  • Record lowest CD4 count and highest viral load ever documented 1

Laboratory Evaluation

  1. CD4 cell count and viral load measurement
  2. Complete blood count
  3. Comprehensive metabolic panel
  4. STI screening:
    • Serologic test for syphilis
    • Nucleic acid amplification tests for gonorrhea and chlamydia
    • Hepatitis B and C serologies 1

Additional Testing Based on Risk Factors

  • For women: Examination for Trichomonas and cervical specimen for chlamydia
  • For patients reporting receptive anal sex: Rectal cultures for gonorrhea and chlamydia
  • For patients reporting receptive oral sex: Pharyngeal culture for gonorrhea 1

Treatment Approach

Antiretroviral Therapy (ART)

  • Initiate ART promptly after diagnosis to:
    • Slow immune system decline
    • Reduce risk of opportunistic infections
    • Decrease risk of HIV transmission 1

Prophylaxis for Opportunistic Infections

  • Based on CD4 count, provide prophylaxis for:
    • Pneumocystis pneumonia (PCP)
    • Tuberculosis
    • Other opportunistic infections 1

Monitoring

  • Regular monitoring of CD4 count and viral load
  • Screening for STIs at least annually, more frequently with high-risk behaviors 1
  • Assessment for treatment adherence and potential drug interactions 1

Counseling and Support

Psychosocial Support

  • Address emotional distress following diagnosis 1
  • Provide counseling on:
    • Accepting potential health implications
    • Coping with stigma
    • Maintaining physical and emotional health
    • Preventing HIV transmission 1

Prevention Counseling

  • Discuss risk reduction strategies
  • Provide guidance on safer sex practices and condom use 2
  • Address substance use if applicable 1

Common Pitfalls to Avoid

  1. Window Period Misinterpretation: Remember that antibody tests cannot rule out infection that occurred less than 6 months before testing 1

  2. False Positives with Viral Load: Low copy number viral load results (<5,000 copies/mL) outside the setting of acute infection may be false positives and should prompt retesting 1

  3. Missing HIV-2: Consider HIV-2 in patients with atypical serologic results, especially those with epidemiological links to West Africa 1

  4. Infant Diagnosis Errors: Don't rely on antibody tests for infants born to HIV-positive mothers; use virologic assays instead 1

  5. Delayed Diagnosis: Don't wait for symptoms to develop; early diagnosis and treatment significantly improve outcomes and reduce transmission 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.